Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Consider this...

Consider this...

posted on Apr 08, 2008 06:38PM

For sake of example, Yahoo Finance has annual EPS at .05, producing a current P/E of 10. Quarterly earnings filed tomorrow may come in somewhere between .10- and .20/share, at least (IMHO). That alone should drive the share price into the $1.00-$2.50 range, assuming no P/E ratio expansion. It may take a little while to get there since PTSC currently trades on a rug bazaar of an exchange, but I am confident it will.

I firmly believe the J's had to pay through the nose, though part of the settlement may not hit this quarter's earnings, depending on how the agreement was structured and when the amounts are effectively earned (if based on future J sales or other contingencies, they will be future revenues and earnings to PTSC).

Tomorrow's boffo earnings should immediately be reflected in countless valuation models and screens. At one time didn't PTSC appear as a "buy" on Joel Greenblatt's Magic Formula Investing website? We may be setting up for similar exposure. PTSC may be a BB stock, but it is unique in its ability to drop big $$$ straight to the bottom line, and there are plenty of private investment pools, hedge funds, etc. not subject to standard institutional restrictions on penny stocks that should want a piece of that action. A little PR to help get the word out would be nice. My 2 cents worth, and all MHO. GLTAL.

Share
New Message
Please login to post a reply